Get access to our best features
Get access to our best features
Published 1 year ago

Research shows minimally invasive procedure saves most patients with severe vascular disease from amputation

Summary by Ground News
LimFlow therapy could lead to the first FDA approval of a therapy giving thousands of patients hope for an alternative to limb loss. LimFlow bypasses blocked arteries in the leg and rush blood back into the foot through the veins. At six months post-procedure, 76 percent of patients were able to keep their leg (also called limb salvage)

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics